BG2109
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BG2109, covering 2023-03-21 to 2023-07-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis [Phase 3]